You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bimekizumab

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)

Not yet recruiting
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Placebo
  • Bimekizumab
  • (no location specified)
Aug 21, 2023

Psoriasis Vulgaris, Active Psoriatic Arthritis Trial (Bimekizumab)

Not yet recruiting
  • Psoriasis Vulgaris
  • Active Psoriatic Arthritis
  • Bimekizumab
  • (no location specified)
Aug 10, 2022

Healthy Study Participants Trial in Glendale, Berlin (bimekizumab)

Active, not recruiting
  • Healthy Study Participants
  • bimekizumab
  • Glendale, California
  • +1 more
Sep 20, 2022

Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab, Placebo)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • Bimekizumab
  • Placebo
  • Bexley, Ohio
  • +7 more
Sep 30, 2022

Moderate to Severe Plaque Psoriasis Trial in Worldwide (bimekizumab)

Active, not recruiting
  • Moderate to Severe Plaque Psoriasis
  • bimekizumab
  • Indianapolis, Indiana
  • +10 more
Aug 19, 2022

Moderate to Severe Plaque Psoriasis Trial in Korea, Republic of (bimekizumab, Placebo)

Active, not recruiting
  • Moderate to Severe Plaque Psoriasis
  • bimekizumab
  • Placebo
  • Bucheon-si, Korea, Republic of
  • +8 more
Jul 28, 2022

Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • Bimekizumab
  • High Point, North Carolina
  • +9 more
Mar 3, 2022

Healthy Volunteers Trial in Harrow (Bimekizumab)

Completed
  • Healthy Volunteers
  • Bimekizumab
  • Harrow, United Kingdom
    (unnamed)
Aug 25, 2021

Healthy Study Participants Trial in Berlin (Bimekizumab)

Terminated
  • Healthy Study Participants
  • Bimekizumab
  • Berlin, Germany
    Up0068 001
Aug 12, 2021

Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab, Placebo)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • Bimekizumab
  • Placebo
  • Los Angeles, California
  • +35 more
Sep 27, 2022

Ankylosing Spondylitis Trial in Worldwide (Bimekizumab)

Completed
  • Ankylosing Spondylitis
  • Bimekizumab
  • Sarasota, Florida
  • +49 more
Nov 17, 2022

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Adalimumab, Placebo)

Completed
Has Results
  • Hidradenitis Suppurativa
  • Bimekizumab
  • +2 more
  • Los Angeles, California
  • +30 more
Mar 14, 2022

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab, Secukinumab, Placebo)

Active, not recruiting
Has Results
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Bimekizumab
  • +2 more
  • Santa Ana, California
  • +76 more
Jan 25, 2023

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Bimekizumab
  • Placebo
  • Birmingham, Alabama
  • +87 more
Feb 2, 2023

Psoriatic Arthritis Trial in Worldwide (Bimekizumab)

Completed
  • Psoriatic Arthritis
  • Bimekizumab
  • Lexington, Kentucky
  • +36 more
Oct 28, 2021

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Completed
  • Hidradenitis Suppurativa
  • Bimekizumab
  • Placebo
  • Fountain Valley, California
  • +90 more
Nov 8, 2022

Nonradiographic Axial Spondyloarthritis Trial in Worldwide (Bimekizumab, Placebo)

Active, not recruiting
  • Nonradiographic Axial Spondyloarthritis
  • Bimekizumab
  • Placebo
  • Mesa, Arizona
  • +82 more
Aug 23, 2022

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis Trial in Worldwide (Bimekizumab,

Completed
Has Results
  • Chronic Plaque Psoriasis
  • +2 more
  • Bimekizumab
  • Placebo
  • San Diego, California
  • +76 more
Jul 15, 2022

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Canada, United States (Bimekizumab)

Completed
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Bimekizumab
  • Phoenix, Arizona
  • +38 more
Jan 6, 2022

Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpa Trial in Worldwide (Bimekizumab)

Enrolling by invitation
  • Axial Spondyloarthritis
  • +2 more
  • Bimekizumab
  • Glendale, Arizona
  • +72 more
Mar 24, 2022

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Brussels, Belgium
  • +18 more
Dec 5, 2022

Healthy Volunteers Trial in San Antonio (Bimekizumab)

Completed
  • Healthy Volunteers
  • Bimekizumab
  • San Antonio, Texas
    Up0034 001
Sep 16, 2020

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis Trial in Worldwide (Bimekizumab,

Completed
Has Results
  • Chronic Plaque Psoriasis
  • +2 more
  • Bimekizumab
  • +2 more
  • Phoenix, Arizona
  • +104 more
Jul 15, 2022

Psoriatic Arthritis Trial in Worldwide (Bimekizumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Bimekizumab
  • Placebo
  • Phoenix, Arizona
  • +92 more
Mar 14, 2022

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab)

Enrolling by invitation
  • Hidradenitis Suppurativa
  • Bimekizumab
  • Birmingham, Alabama
  • +136 more
Jul 26, 2022